EORTC-CLTG

Program

Schedule
Focus

The current provisional program can be downloaded here.
This program is subject to ongoing changes, which will be updated and published at regular intervals.

Download Program

Information in general

We aim to provide an all-encompassing conference where participants can present new research, exchange experiences, and engage in discussions about the latest advancements and emerging directions in the cross-disciplinary field of skin lymphoma, lymphoproliferative disorders, skin cancer, and both malignant and benign inflammation.

Conference Focus

The conference will present sessions covering all aspects of cutaneous lymphomas

The CLTG Annual Meeting has evolved into the world’s largest and most comprehensive conference dedicated to the unique interface between skin cancer and inflammation, specifically cutaneous lymphoma.

International experts will present the latest findings from clinical and preclinical research, as well as insights from ongoing and recently completed clinical trials. Sessions will explore significant advances in foundational science, the definition of high-priority research and development goals, current challenges in clinical practice, and innovative approaches to improving the treatment and overall management of skin lymphomas and related inflammatory disorders.

Keynote and selected speakers will provide high-level overview presentations on emerging scientific developments expected to shape the future of this field. By the conclusion of the meeting, participants will have gained an in-depth and up-to-date understanding of this highly specialized and rapidly evolving discipline.

Core scientific and clinical themes include:

  • Pathophysiology, genomics and epigenomics, molecular targets

  • Immunology, host response, animal models, microenvironment

  • Translational research, diagnostic and prognostic markers

  • Pathology

  • Epidemiology

  • PROCLIPI research initiatives

  • New treatments, clinical trials, topical and systemic therapies, combination approaches, therapeutic strategies

  • Quality of life and patient-reported outcomes